HugoScore hugoscore.org

Patient care navigation and health copilot AI

RTHM

RTHM documents controls to dismiss suspected diagnoses and delete conversations. These provide practical ways to redirect the service, with deletion exceptions and model-use conditions still relevant. Clinical interpretation and underlying record correction remain separate questions.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Mixed6 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Mixed 6 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: RTHM intelligence platform (AI assistant 'Ana', record analysis, optional HIE record retrieval); RTHM Clinic telehealth and prescribing assessed only where it touches the AI platform

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
are generated by artificial intelligence (AI) systems Source

Beta Program and AI Disclosure; Terms section 6 also names the AI navigation assistant 'Ana'.

2. Operator and model maker namedNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

RTHM, Inc. is named. The Sick Times quotes a co-founder saying the platform is built on 'general AI models', with no maker named on RTHM pages.

3. Patient chooses to use itYesdocumented
Not independently replicated
Signing up and interacting with the RTHM intelligence platform is free. Source

Patient signs up. Support: 'When you decide to level up your care by ordering a medication or lab via RTHM or joining the RTHM Clinic, you will be prompted to pay'.

4. Patient sets the taskNodocumented
Not independently replicated
gathers information about you through a chat feature to provide personalized guidance about the medications available through RTHM Source

Terms section 6. The AI is documented as steering toward RTHM's own medications and clinic.

5. Patient can decline or stopYesdocumented
Not independently replicated
Signing up and interacting with the RTHM intelligence platform is free. Source

Self-started rule applied (cites question 3 source). The Sick Times: RTHM's telehealth service 'is separate from its intelligence platform'. Whether prescribing intake requires using Ana is not documented.

6. Patient sees the AI outputYesdocumented
Not independently replicated
You can view your chat history in your account and delete specific conversations if desired. Source

Support FAQ. Suspected diagnoses are also listed in the account.

7. Patient can correct or challengeYesdocumented
Not independently replicated
These are listed for your review; you can manually confirm them if they are established diagnoses or dismiss them if they are inaccurate. Source

Applies to suspected diagnoses flagged by analysis. A route to contest chat answers is not documented.

8. Patient can get a copyNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Support says clinic patients can 'download your clinical data' (clinic scope). No export of platform AI output or uploaded records is documented.

9. Patient can deleteYesdocumented
Not independently replicated
This will remove your profile and personal data from our systems Source

Support: Delete Account in Profile settings; 'some clinical assessment records must be retained for legal compliance'.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
may be used by RTHM or Medical Group to train, develop, enhance, evolve and improve the Service and the underlying AI models Source

Terms (User Information license). Privacy says Google Health wearable data is not used to train generalized models, but no general opt-out. Support says data is used to 'improve the service'.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted only.

12. No advertising or data businessNodocumented
Not independently replicated
may disclose, aggregate, sell, or otherwise use such de-identified information to third parties for analytics, research, or other purposes Source

Terms also allow use 'for marketing and promotional purposes'. Privacy: Google Ads remarketing and advertising-network targeting. Support says 'We do not sell your data to third parties', which conflicts with Terms on de-identified data; answered by binding Terms.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

Leans expandsEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Potentially agency-expanding, with vendor-funnel and data-use caveats

Legacy editorial placement, pre-method: 70

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does RTHM serve in this deployment?
Control RTHM intelligence platform (AI assistant 'Ana', record analysis, optional HIE record retrieval); RTHM Clinic telehealth and prescribing assessed only where it touches the AI platform
Agency read Mixed
Vendor
RTHM, Inc.
Who it serves
Hybrid patient-facing complex-care AI and vendor-controlled virtual care platform
Primary User
Patients with Long COVID, ME/CFS, POTS, MCAS, hEDS, and related complex chronic conditions
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Moderate for published controls and terms (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Legacy editorial placement, pre-method: 70

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 70. Not comparable with v1.3 positions.

Potentially agency-expanding, with vendor-funnel and data-use caveats

RTHM documents controls to dismiss suspected diagnoses and delete conversations. These provide practical ways to redirect the service, with deletion exceptions and model-use conditions still relevant. Clinical interpretation and underlying record correction remain separate questions.

Patient agency

How this tool changes agency

Expands agency when

Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.

Limits agency when

Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified

Patient agency assessment

Who sets and changes the goal?

Patient authority

The ability to dismiss a suspected diagnosis is substantive control over the platform's representation of the patient. Optional HIE participation and care-team sharing provide further choices.

What can the patient understand, question, or do?

Critical capacity

Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.

Can the patient evaluate the conditions of use?

Informed control

The FAQ explains reciprocal HIE exchange and its alternative. Training and derivative-use permissions remain material conditions despite simplified no-sale wording.

Text findings

Conditions of use

Published controls and their limits

The FAQ explains reciprocal HIE exchange and its alternative. Training and derivative-use permissions remain material conditions despite simplified no-sale wording.

What remains unknown?

Not tested or not established

Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Moderate for published controls and terms (AI-assisted draft)